Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BE.12NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.96NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
L.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.310NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.185NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.258.9NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.329NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.229NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.342NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.90NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.169NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.53NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.4.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.528NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.175NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.6.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.483NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.181NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.113NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.594NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.328NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.13NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.145NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.547NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.247NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.4.6NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.205NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.110NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.434NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.4.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.181NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.6.6NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.37NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BF.22NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.2.21NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-19681.5Japan
BA.5.2.22NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BF.10NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BF.38NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-6001.99Japan
BF.38.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-6001.99Japan
BF.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BT.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.2.55NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.76NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.1.30NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BE.11NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.2.9NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BF.31NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-6001.99Japan
BA.4.6NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BF.24NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BF.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used